Cargando…
Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns
BACKGROUND: Increased and inappropriate antimicrobial use are the key drivers of the emergence of antimicrobial resistance, and there have been widespread concerns around potential antimicrobial misuse, overuse and their consequences during the COVID-19 pandemic. To better understand the impact of t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128331/ https://www.ncbi.nlm.nih.gov/pubmed/35610597 http://dx.doi.org/10.1186/s12879-022-07405-3 |
_version_ | 1784712542295162880 |
---|---|
author | Nakitanda, Aya Olivia Karlsson, Pär Löfling, Lukas Cesta, Carolyn E. Odsbu, Ingvild |
author_facet | Nakitanda, Aya Olivia Karlsson, Pär Löfling, Lukas Cesta, Carolyn E. Odsbu, Ingvild |
author_sort | Nakitanda, Aya Olivia |
collection | PubMed |
description | BACKGROUND: Increased and inappropriate antimicrobial use are the key drivers of the emergence of antimicrobial resistance, and there have been widespread concerns around potential antimicrobial misuse, overuse and their consequences during the COVID-19 pandemic. To better understand the impact of the pandemic on antimicrobial use, particularly in light of the resurgence of COVID-19 cases since the summer of 2020, we assessed trends in antimicrobial prescription fills and hospital requisitions in Sweden during 2020 against those of preceding years. METHODS: We performed a descriptive study using population-based data from the Swedish Prescribed Drug Register and the Swedish e-Health Agency. The weekly number of prescriptions filled and the total volume sold to inpatient care institutions in defined daily doses (DDDs) per 1000 inhabitants for systemic antibacterials (Anatomical Therapeutic Chemical therapeutic subgroup J01 excluding J01XX), antimycotics (J02), antivirals (J05) and antiprotozoals (P01) were computed and evaluated from time series graphs. A time series linear regression with ordinary least squares (OLS) estimation was used to model 2015–2019 data and predict the expected number of prescriptions filled and volumes sold in DDDs per 1000 inhabitants during 2020 with 95% confidence limits. RESULTS: From mid-March 2020, the weekly rate of antibiotic and antiprotozoal prescriptions filled plummeted to unprecedentedly low levels for the rest of the year; while unprecedentedly high numbers of antiviral prescriptions were filled weekly between mid-February and mid-March 2020. There was a net reduction in annual dispensing of antibiotics by 17%; of antiprotozoals by 21%; and of antivirals by 0.3% during 2020 compared to 2019. Inpatient care requisitions of antiprotozoals and antibiotics surged to 6-year highs during March 2020, resulting in a 127% increase in DDDs of antiprotozoals sold from 2019. The volume of antibiotics and antivirals sold to inpatient care institutions in 2020 decreased by 3% and 13% compared to 2019, respectively. CONCLUSIONS: The overall decline in antimicrobial prescriptions filled in Sweden during 2020 were in part, collateral dividends of the COVID-19 pandemic. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07405-3. |
format | Online Article Text |
id | pubmed-9128331 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-91283312022-05-24 Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns Nakitanda, Aya Olivia Karlsson, Pär Löfling, Lukas Cesta, Carolyn E. Odsbu, Ingvild BMC Infect Dis Research BACKGROUND: Increased and inappropriate antimicrobial use are the key drivers of the emergence of antimicrobial resistance, and there have been widespread concerns around potential antimicrobial misuse, overuse and their consequences during the COVID-19 pandemic. To better understand the impact of the pandemic on antimicrobial use, particularly in light of the resurgence of COVID-19 cases since the summer of 2020, we assessed trends in antimicrobial prescription fills and hospital requisitions in Sweden during 2020 against those of preceding years. METHODS: We performed a descriptive study using population-based data from the Swedish Prescribed Drug Register and the Swedish e-Health Agency. The weekly number of prescriptions filled and the total volume sold to inpatient care institutions in defined daily doses (DDDs) per 1000 inhabitants for systemic antibacterials (Anatomical Therapeutic Chemical therapeutic subgroup J01 excluding J01XX), antimycotics (J02), antivirals (J05) and antiprotozoals (P01) were computed and evaluated from time series graphs. A time series linear regression with ordinary least squares (OLS) estimation was used to model 2015–2019 data and predict the expected number of prescriptions filled and volumes sold in DDDs per 1000 inhabitants during 2020 with 95% confidence limits. RESULTS: From mid-March 2020, the weekly rate of antibiotic and antiprotozoal prescriptions filled plummeted to unprecedentedly low levels for the rest of the year; while unprecedentedly high numbers of antiviral prescriptions were filled weekly between mid-February and mid-March 2020. There was a net reduction in annual dispensing of antibiotics by 17%; of antiprotozoals by 21%; and of antivirals by 0.3% during 2020 compared to 2019. Inpatient care requisitions of antiprotozoals and antibiotics surged to 6-year highs during March 2020, resulting in a 127% increase in DDDs of antiprotozoals sold from 2019. The volume of antibiotics and antivirals sold to inpatient care institutions in 2020 decreased by 3% and 13% compared to 2019, respectively. CONCLUSIONS: The overall decline in antimicrobial prescriptions filled in Sweden during 2020 were in part, collateral dividends of the COVID-19 pandemic. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07405-3. BioMed Central 2022-05-24 /pmc/articles/PMC9128331/ /pubmed/35610597 http://dx.doi.org/10.1186/s12879-022-07405-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Nakitanda, Aya Olivia Karlsson, Pär Löfling, Lukas Cesta, Carolyn E. Odsbu, Ingvild Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns |
title | Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns |
title_full | Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns |
title_fullStr | Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns |
title_full_unstemmed | Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns |
title_short | Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns |
title_sort | antimicrobial use in sweden during the covid-19 pandemic: prescription fill and inpatient care requisition patterns |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128331/ https://www.ncbi.nlm.nih.gov/pubmed/35610597 http://dx.doi.org/10.1186/s12879-022-07405-3 |
work_keys_str_mv | AT nakitandaayaolivia antimicrobialuseinswedenduringthecovid19pandemicprescriptionfillandinpatientcarerequisitionpatterns AT karlssonpar antimicrobialuseinswedenduringthecovid19pandemicprescriptionfillandinpatientcarerequisitionpatterns AT loflinglukas antimicrobialuseinswedenduringthecovid19pandemicprescriptionfillandinpatientcarerequisitionpatterns AT cestacarolyne antimicrobialuseinswedenduringthecovid19pandemicprescriptionfillandinpatientcarerequisitionpatterns AT odsbuingvild antimicrobialuseinswedenduringthecovid19pandemicprescriptionfillandinpatientcarerequisitionpatterns |